Patent details

EP2298780 Title: Antitumoral derivatives of Ecteinascidin ET-743

Basic Information

Publication number:
EP2298780
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP101800498
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Antitumoral derivatives of Ecteinascidin ET-743
French Title of Invention:
Dérivés d'ecteinascidin (ET-743) en tant qu'agents tumoraux
German Title of Invention:
Tumorhemmende derivate von Ecteinascidin ET-743
SPC Number:

Dates

Filing date:
17/07/2002
Grant date:
12/09/2012
EP Publication Date:
12/09/2012
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/03/2011
EP B1 Publication Date:
12/09/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
17/07/2013
Expiration date:
17/07/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/07/2002
 
 

Name:
PHARMA MAR S.A.
Address:
Calle de la Calera 3, Poligono Industrial de Tres Cantos, 28760 Tres Cantos, Madrid, Spain (ES)

Inventor

1

Name:
Gallego Pilar
Address:
Spain (ES)

2

Name:
Cuevas Carmen
Address:
Spain (ES)

3

Name:
Flores Maria
Address:
Spain (ES)

4

Name:
Munt Simon
Address:
Spain (ES)

5

Name:
Manzanares Ignacio
Address:
Spain (ES)

6

Name:
Martinez Valentin
Address:
Spain (ES)

Priority

Priority Number:
0117402
Priority Date:
17/07/2001
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
C07D 515/22;
Filing date Document type Number of pages